Karlijn Verkerk
Karlijn Verkerk publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics and Melanoma and MAPK Pathways.
- World rank
- #1,724,121 of 7,710,434 ranked researchers
- Rank in Netherlands
- #38,182 of 107,149
- Works
- 61
- Citations
- 106
- Citations per work
- 1.7
What does Karlijn Verkerk research?
Karlijn Verkerk's work is mostly in Medicine (52%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3251.8%
- Medicine3251.8%
- Life Sciences1626.8%
- Everything else1321.4%
- 1Oncology34% of their works
- 2Pulmonary and Respiratory Medicine14% of their works
- 3Molecular Biology12% of their works
- 4Cancer Research9% of their works
- 5Immunology5% of their works
- 6Physiology4% of their works
Research topics
Which keywords describe Karlijn Verkerk's research?
The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Targeted Therapy, Cancer Therapy, Clinical Trials, Cancer Genomics, Mutational Signatures and ALK Inhibitors.
- Regulatory Challenges
- Brain Metastases
- BRCA Mutation
- KRAS Mutations
- Cetuximab
- ALK Inhibitors
- Cancer Genomics
- Cancer Therapy
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Targeted Therapy
- Clinical Trials
- Mutational Signatures
- BRAF gene
- EGFR Mutations
- MAP Kinase
- PARP Inhibitors
- Radiosurgery
- Stem Cell Regulation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Immune Checkpoint Blockade91 topic
- PD-1 and PD-L191 topic
- Targeted Therapy92 topics
- Cancer Therapy72 topics
- Clinical Trials62 topics
- Cancer Genomics51 topic
- Mutational Signatures51 topic
- ALK Inhibitors41 topic
- BRAF gene41 topic
- Cetuximab41 topic
- EGFR Mutations41 topic
- KRAS Mutations41 topic
- MAP Kinase41 topic
- BRCA Mutation31 topic
- PARP Inhibitors31 topic
- Brain Metastases21 topic
- Radiosurgery21 topic
- Regulatory Challenges21 topic
- Stem Cell Regulation21 topic
Where does Karlijn Verkerk work?
Karlijn Verkerk's main affiliation in the publication record is Oncode Institute, Netherlands.
How many publications and citations does Karlijn Verkerk have?
OpenAlex counts 61 works and 106 citations for Karlijn Verkerk, an h-index of 5, ranking #1,724,121 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Karlijn Verkerk. Posts are plain text and can be reported.